Heart Disease News and Research

Latest Heart Disease News and Research

Drugs' cost deters patients from taking heart medicine

For more than 5 million Americans with heart failure, a critical step to better health is taking the medications they're prescribed. But many patients fail to do so, putting themselves at greater risk of hospitalization and even death. To date, studies have not fully answered why patients fall short when it comes to taking heart medicine. In a study appearing in the April issue of Mayo Clinic Proceedings, Mayo Clinic researchers found the drugs' cost is one of the biggest deterrents.

30 Mar 2011

BIOTRONIK completes patient enrollment in IN-TIME clinical trial to treat HF

BIOTRONIK SE & Co. KG, a leading manufacturer of cardiac devices, announced today that the last chronic heart failure patient was enrolled in IN-TIME at the Schwabing Clinic in Munich, Germany, with principle investigator Professor Stefan Sack, MD.

30 Mar 2011

EC grants marketing authorization for GSK, Valeant's Trobalt to treat epilepsy

GlaxoSmithKline and Valeant Pharmaceuticals International, Inc. announced today that the European Commission has granted marketing authorisation for Trobalt as an adjunctive treatment of partial onset seizures, with or without secondary generalisation in adults aged 18 years and above with epilepsy.

30 Mar 2011

Intercept initiates OCA FLINT trial in patients with nonalcoholic steatohepatitis

Intercept Pharmaceuticals, Inc., has been informed by the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health that patient enrollment has started in a new clinical trial in patients with nonalcoholic steatohepatitis, which will evaluate Intercept's first-in-class farnesoid X receptor agonist obeticholic acid as a novel therapy for NASH.

30 Mar 2011

Metabolic Solutions initiates MSDC-0602 Phase 2a trial in patients with type 2 diabetes

Metabolic Solutions Development Company, a drug discovery and development company exploiting novel molecular targets to treat metabolic diseases, announced today that it has launched a Phase 2a trial for MSDC-0602, the company's second drug candidate for the treatment of type 2 diabetes.

30 Mar 2011

Australian researchers say the search must widen for genes that cause heart defects in babies

Australian scientists have discovered a new group of genes that could be responsible for causing heart defects in children, which affect more than 2000 babies born each year in Australia.

29 Mar 2011

Stress affects sleep, mood and body weight: Study

In a new study that appeared in the International Journal of Obesity, researchers have found that stress may affect sleep, mood and ultimately body weight. The study found that people with high stress and poor sleep were less likely to achieve a 10-lb. weight loss goal.

29 Mar 2011

Bariatric surgery highly cost-effective treatment for obese type 2 diabetics

Bariatric surgery is an especially cost-effective therapy for managing Type 2 diabetes in moderately and severely obese patients. These findings and others were presented today at the 2nd World Congress on Interventional Therapies for Type 2 Diabetes, hosted by NewYork-Presbyterian Hospital and Weill Cornell Medical College.

29 Mar 2011

CryoLife to acquire Cardiogenesis

CryoLife, Inc., an implantable biological medical device and cardiovascular tissue processing company, and Cardiogenesis Corporation, a leading developer of surgical products used in the treatment of patients with refractory angina resulting from diffuse coronary artery disease, today announced that the boards of directors of both companies have approved a definitive agreement under which CryoLife will acquire all of the outstanding shares of Cardiogenesis for $0.457 per share.

29 Mar 2011

IOM report recommends steps to ensure LGBT health research gaps and needs

Recent findings on the differences in heart disease among women and men and among blacks and whites show that characteristics such as gender and ethnicity matter when it comes to health research.

29 Mar 2011

People of all ages and both sexes can have congestive heart failure

Elizabeth Taylor died of congestive heart failure at the age of 79 on March 23. Her death raises awareness of this serious condition that affects an estimated five million Americans.

29 Mar 2011

McKesson awards GW with two grants to study mobile-phone use in diabetic patients

GW researchers have been awarded two grants from the McKesson Foundation as part of its Mobilizing for Health initiative, an initiative to improve the health of underserved populations with chronic diseases through the use of mobile-phone technology.

29 Mar 2011

New guidelines highlight genetic testing use in heart arrhythmia clinical management

The Canadian Cardiovascular Society and Canadian Heart Rhythm Society have produced the first-ever comprehensive guidelines on the use of genetic testing in the clinical management of inherited heart rhythm disorders, released in the March/April issue of the Canadian Journal of Cardiology published by Elsevier.

29 Mar 2011

AHA, ACC applaud IOM for its new report on clinical practice guidelines

Few issues are more important to the American College of Cardiology and the American Heart Association than translating scientific evidence into guidelines and performance measures for healthcare providers, a process we have been engaged in for several decades.

29 Mar 2011

Study links specific cardiovascular risk factors to AF episodes

Reducing cardiovascular risk factors like high blood pressure, smoking, diabetes and being overweight could potentially reduce more than half of all cases of atrial fibrillation, according to research reported in Circulation: Journal of the American Heart Association.

29 Mar 2011

Doctors who use iResus application perform better simulated cardiac arrest emergency

Doctors who used a free iPhone application provided by the UK Resuscitation Council performed significantly better in a simulated medical emergency than those who did not, according to a study in the April issue of Anaesthesia.

29 Mar 2011

Study: Donor's DNA level in heart transplant recipient's blood can reveal organ rejection

Heart transplant recipients and their physicians are likely more concerned with the function of the donated organ than with the donor's DNA sequences that tag along in the new, healthy tissue.

29 Mar 2011

IDF: Obese people with type 2 diabetes can benefit from bariatric surgery

Bariatric surgery should be considered earlier in the treatment of eligible patients to help stem the serious complications that can result from diabetes, according to an International Diabetes Federation position statement presented by leading experts at the 2nd World Congress on Interventional Therapies for Type 2 Diabetes in New York.

29 Mar 2011

Regado to present REG1 Phase 2b trial results against acute coronary syndromes at i2 Summit

Regado Biosciences, Inc., a privately held company pioneering the development of antithrombotic aptamers with active control agents, announced that Thomas J. Povsic, MD, PhD, Assistant Professor of Medicine at Duke University, will present results of the RADAR Phase 2b clinical trial for the Company's lead product, the REG1 anticoagulation system, at the i2 Summit during the American College of Cardiology 2011 60th Annual Scientific Session & Expo.

29 Mar 2011

Interventional radiologists complete RDN human trial in patients with uncontrolled hypertension

Interventional radiologists have completed the first human randomized controlled trial of therapeutic renal denervation or RDN—a procedure that uses a catheter-based probe inserted into the renal artery that emits high-frequency energy to deactivate the nerves near the kidneys that are linked to high blood pressure.

29 Mar 2011

Heart Disease News and Research

Latest Heart Disease News and Research

Drugs' cost deters patients from taking heart medicine

BIOTRONIK completes patient enrollment in IN-TIME clinical trial to treat HF

EC grants marketing authorization for GSK, Valeant's Trobalt to treat epilepsy

Intercept initiates OCA FLINT trial in patients with nonalcoholic steatohepatitis

Metabolic Solutions initiates MSDC-0602 Phase 2a trial in patients with type 2 diabetes

Australian researchers say the search must widen for genes that cause heart defects in babies

Stress affects sleep, mood and body weight: Study

Bariatric surgery highly cost-effective treatment for obese type 2 diabetics

CryoLife to acquire Cardiogenesis

IOM report recommends steps to ensure LGBT health research gaps and needs

People of all ages and both sexes can have congestive heart failure

McKesson awards GW with two grants to study mobile-phone use in diabetic patients

New guidelines highlight genetic testing use in heart arrhythmia clinical management

AHA, ACC applaud IOM for its new report on clinical practice guidelines

Study links specific cardiovascular risk factors to AF episodes

Doctors who use iResus application perform better simulated cardiac arrest emergency

Study: Donor's DNA level in heart transplant recipient's blood can reveal organ rejection

IDF: Obese people with type 2 diabetes can benefit from bariatric surgery

Regado to present REG1 Phase 2b trial results against acute coronary syndromes at i2 Summit

Interventional radiologists complete RDN human trial in patients with uncontrolled hypertension

Forensics and toxicology - Industry Focus eBook eBook

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Heart Disease News and Research

Latest Heart Disease News and Research

Forensics and toxicology - Industry Focus eBook eBook

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Newsletters you may be interested in